Found 4 matching trials
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
PHASE3All randomised patients with Charcot-Marie-Tooth Type 1A (CMT1A) who comple...
Location
Department of Neurology, Cedars-Sinai Medical Center
Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A
PHASE2The present trial is a randomized, placebo-controlled study evaluating 3 di...
Location
Hôpital Roger Salengro
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients
PHASE3The study will consist of 2 periods: Double-blind Treatment and Open-Label ...
Location
Cedars-Sinai Medical Center
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
PHASE3The purpose of this study is to determine whether PXT3003 is effective and ...
Location
Department of Neurology, Cedars-Sinai Medical Center